Table 2.
Comparison of PMI and outcomes between two groups
| Characteristic | Sarcopenia (n = 37, 35.9%) |
No sarcopenia (n = 66, 64.1%) |
p |
|---|---|---|---|
| CT-to-surgery interval (days) | 6 (5, 9.5) | 5 (3, 9) | 0.24 |
| PMI (mm2/m2) | |||
| Male | 440.37 (387.74, 505.34) | 658.32 (601.86, 760.76) | < 0.001** |
| Female | 308.90 (253.53, 339.47) | 489.01 (446.94, 611.14) | < 0.001** |
| Abdominal complications | 3 | 5 | 0.16 |
| Postoperative stay (days) | 10 (8, 11) | 9 (8, 10.25) | 0.16 |
| Leukopenia | |||
| 7 days after surgery | 1 | 5 | 0.42 |
| Before first postoperative chemotherapy | 10 | 9 | 0.093 |
| Neutropenia | |||
| 7 days after surgery | 0 | 2 | 0.54 |
| Before first postoperative chemotherapy | 11 | 6 | 0.007* |
PMI psoas muscle index
*p < 0.05; **p < 0.01